M. Klein

发表

End-stage renal disease among HIV-infected adults in North America.

Sally S Bebawy, K. Anastos, S. Gange, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012–2016

Jun Yu Li, S. Gange, J. Willig, 2023, PloS one.

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.

Richard D Moore, K. Anastos, S. Gange, 2019, The lancet. HIV.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Michael J Silverberg, Bryan Lau, Michael S Saag, 2009, The New England journal of medicine.

The new england journal of medicine Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

J. Goedert, B. Lau, R. Hogg, 2009 .

Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection

G. Sebastiani, G. Guaraldi, T. Krahn, 2020, The Journal of Infectious Diseases.

Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans.

Paige L. Williams, E. T. Tchetgen Tchetgen, A. Justice, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.

Richard D Moore, J. Goedert, Jeffrey N. Martin, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?

M. Horberg, S. Deeks, K. Gebo, 2010, AIDS research and therapy.

Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.

Richard D Moore, J. Goedert, E. Moodie, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration.

C. Rentsch, M. van der Valk, A. Trickey, 2023, The lancet. HIV.

Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.

Sally S Bebawy, K. Anastos, S. Gange, 2013, The Journal of infectious diseases.

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study

A. Mocroft, B. Ledergerber, C. Mussini, 2010, The Lancet.

The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.

S. Suissa, R. Lalonde, M. Klein, 2003, Journal of acquired immune deficiency syndromes.

Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States

Sally S Bebawy, Richard D Moore, K. Anastos, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.